Sponsor pipeline

Murdoch Childrens Research Institute clinical trial pipeline

Get alerts when Murdoch Childrens Research Institute's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

8 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 6 with minor changes only.

Show 6 trials with minor changes only
  6. Minor

    Enrollment reduced: 452 → 396 participants

    Also in this update: Primary completion moved earlier from May 16, 2028 to Jan 2028; Study completion moved earlier from May 16, 2028 to Mar 2028

    Murdoch Childrens Research InstitutePhase 4 NCT04876131 Registry history

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-09 NCT07868731 Rapid Escalation Oral Immunotherapy to Achieve Remission in Children With Cashew Allergy Not Yet Recruiting
2026-10-07 NCT07864350 Stopping Strep Throat With Antibodies in Healthy Adults. Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
2
Phase 1/2
1
Phase 2
3
Phase 3
3
Phase 4
8
Not charted: 25 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Anxiety (2) · Depression (2) · Acute Lymphoblastic Leukemia (ALL) (1) · Hodgkin Lymphoma (1) · Leukemia (1) · Non-Hodgkin Lymphoma (1) · Obesity (1) · Rare Disease (1)

Get alerts when Murdoch Childrens Research Institute's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free